LGD-4033, VK5211, Ligandrol CAS 1165910-22-4 LGD-4033 (VK5211, Ligandrol) jest badany selektywny modulator receptora androgenowego (SARM), do leczenia stanów, takich jak zanik mięśni i osteoporozy, odkryty przez Ligand Pharmaceuticals, obecnie w fazie rozwoju przez Wikingów Therapeutics. LGD-4033, VK5211, Ligandrol
LGD-4033,VK5211,Ligandrol CAS 1165910-22-4
LGD-4033 (VK5211, Ligandrol) is an investigational selective androgen receptor modulator (SARM) for treatment of conditions such as muscle wasting and osteoporosis, discovered by Ligand Pharmaceuticals and currently under development by Viking Therapeutics.
LGD-4033, VK5211, Ligandrol